Publicaciones en colaboración con investigadores/as de Dana–Farber Cancer Institute (8)

2024

  1. Noninvasive Detection of Neuroendocrine Prostate Cancer through Targeted Cell-free DNA Methylation

    Cancer Discovery, Vol. 14, Núm. 3, pp. 424-445

2021

  1. Author Correction: Performance assessment of DNA sequencing platforms in the ABRF Next-Generation Sequencing Study (Nature Biotechnology, (2021), 39, 9, (1129-1140), 10.1038/s41587-021-01049-5)

    Nature Biotechnology

  2. Epigenetic encoding, heritability and plasticity of glioma transcriptional cell states

    Nature Genetics, Vol. 53, Núm. 10, pp. 1469-1479

  3. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  4. Performance assessment of DNA sequencing platforms in the ABRF Next-Generation Sequencing Study

    Nature Biotechnology, Vol. 39, Núm. 9, pp. 1129-1140

2020

  1. Circulating tumor DNA profile recognizes transformation to castration-resistant neuroendocrine prostate cancer

    Journal of Clinical Investigation, Vol. 130, Núm. 4, pp. 1653-1668

2019

  1. Corrupted coordination of epigenetic modifications leads to diverging chromatin states and transcriptional heterogeneity in CLL

    Nature Communications, Vol. 10, Núm. 1

  2. Epigenetic evolution and lineage histories of chronic lymphocytic leukaemia

    Nature, Vol. 569, Núm. 7757, pp. 576-580